R&D News | pharmaphorum

News

GSK scientists find new way to fight malaria

A team at GSK has identified what could be an entirely new weapon in the fight to eradicate malaria – but it isn't a new vaccine or antimalarial compound.

News

Dosing prompts Novartis to tap Ionis for second Lp(a) drug

Novartis has turned to Ionis for another cardiovascular disease drug, putting $60 million down for a follow-up to lipoprotein(a)-targeting drug pelacarsen, which is now in

News

PacBio builds in short-read sequencing with $110m Apton buy

Gene sequencing specialist PacBio has reached an agreement to buy Apton Biosystems, boosting its position in short-read sequencing technology that has traditionally been d

News

Marrazzo to succeed Fauci as NIAID director

After months of deliberations, the National Institute of Allergy and Infectious Diseases (NIAID) has a new director to replace Dr Anthony Fauci, who held the role for 38 y

News

Thermo agrees settlement with Henrietta Lacks' family

The family of Henrietta Lacks, an African American woman whose cells have been used in research for decades but were allegedly harvested without her consent, has agreed to

News

EQRx's low-price drugs mission ends with Revolution buy

EQRx's pledge to disrupt the pharma pricing system started with a clarion call in 2020 but ended with a whimper today with an agreement to be taken over by Revolution Medi

GSK scientists find new way to fight malaria

Dosing prompts Novartis to tap Ionis for second Lp(a) drug

PacBio builds in short-read sequencing with $110m Apton buy

Marrazzo to succeed Fauci as NIAID director

Thermo agrees settlement with Henrietta Lacks' family

EQRx's low-price drugs mission ends with Revolution buy

FDA kicks off review of Takeda's narcolepsy hopeful

How to meet your physicians where they are online

News

Editor's Picks